Heptodin



Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis B 63.4%
Hepatic Cirrhosis 13.0%
Product Used For Unknown Indication 7.3%
Chronic Hepatitis B 3.3%
Hepatic Cancer 2.4%
Antiviral Treatment 1.6%
Drug Use For Unknown Indication 1.6%
Hypertension 1.6%
Liver Injury 1.6%
Anorexia 0.8%
Diabetes Mellitus 0.8%
Hepatitis 0.8%
Jaundice 0.8%
Non-hodgkin's Lymphoma 0.8%
Transaminases Increased 13.3%
Product Quality Issue 12.0%
Aspartate Aminotransferase Increased 6.7%
Drug Exposure During Pregnancy 6.7%
Hbv Dna Increased 6.7%
Hepatitis B 6.7%
Pyrexia 5.3%
Viral Hepatitis Carrier 5.3%
Nausea 4.0%
Nephrolithiasis 4.0%
Splenomegaly 4.0%
Thrombocytopenia 4.0%
Albuminuria 2.7%
Discomfort 2.7%
Fatigue 2.7%
Haemolytic Anaemia 2.7%
Malaise 2.7%
Osteonecrosis 2.7%
Pain In Extremity 2.7%
Pharyngitis 2.7%
Secondary
Hepatitis B 79.5%
Hepatic Cirrhosis 11.4%
Liver Injury 6.8%
Chronic Hepatitis B 2.3%
Product Quality Issue 13.5%
Transaminases Increased 10.8%
Drug Resistance 8.1%
Cachexia 5.4%
Drug Ineffective 5.4%
Fatigue 5.4%
Hepatic Cirrhosis 5.4%
Hepatitis 5.4%
Osteomalacia 5.4%
Rash 5.4%
Vomiting 5.4%
Alanine Aminotransferase Increased 2.7%
Asthenia 2.7%
Blood Creatine Phosphokinase Increased 2.7%
Dysphagia 2.7%
Haematemesis 2.7%
Hepatitis B Dna Increased 2.7%
Myalgia 2.7%
Pancytopenia 2.7%
Portal Vein Dilatation 2.7%
Concomitant
Diabetes Mellitus 22.2%
Hepatic Neoplasm Malignant 22.2%
Hepatitis B 22.2%
Liver Transplant 22.2%
Hepatic Function Abnormal 11.1%
Jaundice Cholestatic 40.0%
Liver Transplant Rejection 40.0%
Leukopenia 20.0%